Eric Devroe, Chief Operating Officer at Acrivon Therapeutics, Inc. (ACRV), bought 10,000 shares at $1.72 ($17K) on 2026-01-13, disclosed to the SEC on 2026-01-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.